Biodistribution of rAAV Vectors Following Intraocular Administration: Evidence for the Presence and Persistence of Vector DNA in the Optic Nerve and in the Brain-Reference-Cited by-同舟云学术

Biodistribution of rAAV Vectors Following Intraocular Administration: Evidence for the Presence and Persistence of Vector DNA in the Optic Nerve and in the Brain

Published:2005-02 Issue:2 Volume:11 Page:275-283
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Provost Nathalie,Le Meur Guylène,Weber Michel,Mendes-Madeira Alexandra,Podevin Guillaume,Cherel Yan,Colle Marie-Anne,Deschamps Jack-Yves,Moullier Philippe,Rolling Fabienne

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference26 articles.

1. Gene therapy restores vision in a canine model of childhood blindness;Acland;Nat. Genet.,2001

2. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog;Narfstrom;Invest. Ophthalmol. Visual Sci.,2003

3. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy;Ali;Nat. Genet.,2000

4. AAV-mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa;Smith;Mol. Ther.,2003

5. Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle;Favre;Mol. Ther.,2001

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency;Molecular Therapy - Methods & Clinical Development;2024-03

2. AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery;Frontiers in Drug Delivery;2023-07-12

3. Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks;Molecular Therapy;2023-07

4. Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems;Advanced Drug Delivery Reviews;2023-05

5. Mannose-coupled AAV2: a second generation AAV vector for increased retinal gene therapy efficiency;2022-12-01